Tatjana Kehler

Tatjana Kehler

Auto-generated profile, based on publicly available information

Tatjana Kehler

Hospital for Medical Rehabilitation of Hearth and Lung Diseases and Rheumatis “Thalassotherapia-Opatija”, M. Tita 180, 51410 Opatija, Croatia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PDPatrick Durez
Patrick Durez
PVPierre Vandepapeliere
Pierre Vandepapeliere
PMPedro Miranda
Pedro Miranda
ATAntoaneta Toncheva
Antoaneta Toncheva
ABAlberto Berman
Alberto Berman
MBMarie-Christophe Boissier
Marie-Christophe Boissier
Active immunization, or vaccination, with tumor necrosis factor (TNF)-Kinoid (TNF-K) is a novel approach to induce polyclonal anti-TNF antibodies in immune-mediated inflammatory diseases. This study was performed to transfer the proof of concept obtained in mice model of rheumatoid arthritis (RA) into human. We designed a pilot study to demonstrate the feasibility of therapeutic vaccination in RA. This was a phase IIa, placebo-controlled, multicenter study in adults with RA who previously experienced secondary failure of TNF antagonists. Patients were immunized intramuscularly with 2 or 3 doses of placebo (n = 10) or 90 (n = 6), 180 (n = 12), or 360 µg TNF-K (n = 12). The primary objective was to identify the best dose and schedule based on anti-TNF antibody titers. Clinical symptoms and safety were assessed during 12 months and solicited reactions for 7 days after each injection. The highest anti-TNF antibody response was detected in patients immunized with 360 µg TNF-K and with 3 injections, although this difference was not significant with all other groups. Similar proportions of patients receiving TNF-K and placebo reported adverse events up to month 12. Serious adverse events were reported by 4 patients treated with TNF-K (13.3%) and 3 treated with placebo (30.0%), all unrelated to treatment. At month 12, DAS28-CRP, tender and swollen joint counts, and HAQ scores decreased significantly more in patients who exhibited anti-TNF antibody response than in patients who did not. TNF-K therapeutic vaccination induced dose- and schedule-dependent anti-TNF antibodies in RA patients and was well tolerated. Patients who developed anti-TNF antibodies showed a trend toward clinical improvement. Although the most aggressive dose and schedule, i.e. 360 mg dose administered 3 times, did show a strong trend of higher antibody response, further studies are warranted to examine even higher and more frequent doses in order to establish the best conditions for clinical improvement. ClinicalTrials.gov NCT01040715

10 June 2015 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
LŠLea Šalamon
Lea Šalamon
JMJadranka Morović-Vergles
Jadranka Morović-Vergles
DMDaniela Marasović-Krstulović
Daniela Marasović-Krstulović
TKTatjana Kehler
Tatjana Kehler
DŠDavorin Šakić
Davorin Šakić
SGStjepan Gamulin
Stjepan Gamulin

1 February 2015 in Medical Hypotheses
Verified
Journal Article
Closed access
ADA. Vukic Dugac
A. Vukic Dugac
ARAlen Ružić
Alen Ružić
MSM. Samarzija
M. Samarzija
SBSonja Badovinac
Sonja Badovinac
TKT. Kehler
T. Kehler
MJM. Jakopovic
M. Jakopovic

11 September 2012 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
JMJadranka Morovic-Vergles
Jadranka Morovic-Vergles
LŠLea Šalamon
Lea Šalamon
DMDaniela Marasović-Krstulović
Daniela Marasović-Krstulović
TKTatjana Kehler
Tatjana Kehler
DŠDavorin Šakić
Davorin Šakić
SGStjepan Gamulin
Stjepan Gamulin

1 September 2016 in Medical Hypotheses
Verified
Journal Article
Closed access
GLGordana Laškarin
Gordana Laškarin
VPViktor Persic
Viktor Persic
SKSandra Rusac Kukic
Sandra Rusac Kukic
DMDrazen Massari
Drazen Massari
ALAnita Legovic
Anita Legovic
TKTatjana Kehler
Tatjana Kehler

10 August 2011 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
DMDrazen Massari
Drazen Massari
LPLarisa Prpić-Massari
Larisa Prpić-Massari
TKTatjana Kehler
Tatjana Kehler
MKMarija Kastelan
Marija Kastelan
BCBozidar Curkovic
Bozidar Curkovic
GLGordana Laškarin
Gordana Laškarin